carbidopa/levodopa FDC (HRG2010)
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
May 17, 2025
Relative Bioavailability Study of HRG2010 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=16 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P1 trial • CNS Disorders • Movement Disorders • Parkinson's Disease
January 03, 2025
HRG2010-301: A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
(clinicaltrials.gov)
- P3 | N=450 | Recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders • Movement Disorders • Parkinson's Disease
September 26, 2024
Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations
(clinicaltrials.gov)
- P2 | N=61 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P2 trial • CNS Disorders • Movement Disorders • Parkinson's Disease
September 19, 2024
A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
(clinicaltrials.gov)
- P3 | N=450 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P3 trial • CNS Disorders • Movement Disorders • Parkinson's Disease
1 to 4
Of
4
Go to page
1